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Purpose: Since the 78 kDa glucose-regulated protein (GRP78) is a key marker of endoplasmic reticulum (ER) stress, we
investigated and analyzed GRP78 expression levels in the trabecular meshwork (TM) by eyes with primary open angle
glaucoma (POAG) and normal eyes to understand the role of GRP78 in human TM cells apoptosis.
Methods: Trabecular meshwork cells from POAG patients (GTM) and age-matched non-diseased individuals (NTM)
were cultured and treated with or without the following chemical chaperones: tunicamycin (Tm), which induces ER stress,
and staurosporine (STS), which induce apoptosis, and dimethylsulfoxide (DMSO) as a control, for 6–24 h. Expression of
GRP78 mRNA and protein was measured using real-time PCR and western blot analysis. The intracellular distribution
of GRP78 with myocilin was analyzed using confocal double immunoﬂuorescence.
Results: Both real-time PCR and western blot analysis showed similar results, revealing that GRP78 mRNA expression
and GRP78 protein levels were attenuated in GTM cells compared with NTM cells (65.97±3.8% and 80.49±4.2%,
respectively, p<0.05). After exposure to Tm and following ER stress, increased GRP78 protein levels were detected in
all cells. However, a low fold change of the protein (2.564 versus 2.710 for a 24 h exposure) and lower cell viability were
found in GTM cells compared to NTM cells (p<0.05). Confocal microscopy showed that GRP78 was partly colocalized
with myocilin in GTM cells, but less in NTM cells. After Tm and STS treatment, the colocalization of GRP78 with
myocilin was found in both NTM and GTM cells.
Conclusions: The authors propose that the down-regulation of GRP78 plays a role in the degeneration of TM cells in
POAG patients, thus providing molecular insights into the pathogenesis of POAG and suggesting that GRP78 may have
the potential to be a target for developing new modalities for ER stress-induced TM cell apoptosis.
Glaucoma,  characterized  by  progressive  optic
neuropathy, is the second most common cause of blindness in
the world [1]. Primary open angle glaucoma (POAG) is the
most common form of glaucoma, yet its pathogenesis is still
unknown.  POAG  is  generally  associated  with  elevated
intraocular pressure (IOP) caused by the abnormal resistance
of aqueous outflow through the trabecular meshwork (TM), a
specialized tissue lining the outflow pathway of the eye [2,
3].  Elevated  IOP  can  lead  to  progressive  neuropathy  and
retinal ganglion cell (RGC) death in the retina, conditions that
result in irreversible vision loss [4-7]. It has been suggested
that age- and disease-related changes in TM cells, followed
by substitution with extracellular matrix, contributes to an
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increased resistance to aqueous outflow and causes increased
IOP in POAG patients [8-13].
Endoplasmic reticulum (ER) stress modifies the normal
folding of protein, resulting in accumulation of anomalous
proteins which cause cytotoxicity of a cell’s internal living
environment [14,15]. Both in vitro and in vivo data strongly
indicated that the accumulation of mutant myocilin in the ER
of human trabecular meshwork (HTM) cells is one reason for
the development of myocilin-associated glaucoma [16,17]. A
possible  reason  for  the  inducing  of  glaucoma  by  mutant
MYOC may be the ability of the stressed ER activated the
unfolded  protein  response  (UPR)  to  then  influence  the
synthesis,  folding,  and  sorting  [17-20].  UPR  is  a  signal
transduction cascade that perceives and moderates protein-
folding stress in the ER caused by physiologic constitution or
environmental variation [21]. The 78 kDa glucose-regulated
protein (GRP78) is an abundant multi-functional protein that
binds to each of the ER stress transducers, including PKR-like
ER kinase (PERK),inositol-requiring enzyme 1 (IRE1), and
activating  transcription  factor  6  (ATF6)  and  serves  as  a
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1122transmitter in alterating of ER homeostasis. These proteins
originally generate a cytoprotective signals leading to reduced
translation, then improve ER protein folding capacity, and
clear  misfolded  ER  proteins  [14,15].  Studies  performed
during  the  last  decade  identified  GRP78  as  a  ubiquitous
luminal resident protein of the ER that plays a key role in
assisting  the  corrected  folding  of  protein  tertiary  and
quaternary structures. This is defined as chaperoning, and
implies the direct binding of GRP78 to the growing chains,
with  stimulation  of  its  ATPase  activity  [22,23].
Cytoprotective  outputs  coexist,  along  with  pro-apoptotic
signaling, outweighing this effect in the initial stages of ER
stress.  The  acute  UPR  allows  cells  to  readjust  protein
synthesis and chaperone levels to deal with stress. If these
steps  fail  to  reestablish  homeostasis,  IRE1α  and  ATF6α
signals will be attenuated, creating an imbalance where pro-
apoptotic output guides the cell toward apoptosis [24].
Recently studies indicated a close connection between
GRP78 and ER stress in certain disease processes. The protein
can protects cells from ER stress and its induction is crucial
for maintaining the viability of cells subjected to a variety of
stress treatments [25]. Hayashi et al. [26] found that induction
of GRP78 by ischemic preconditioning reduces endoplasmic
reticulum stress and prevents delayed neuronal cell death. The
overexpression  of  GRP78  results  in  reduced  apoptosis  in
Chinese hamster ovary cells [27] and cardiomyocytes [28].
This effect is associated with the formation of the GRP78-
caspase-7 complex through an ATP-binding domain within
GRP78. The role of GRP78 during stress is not limited to
quality control of the misfolded proteins, but also includes an
increase in Ca2+ buffering within the ER lumen. For example,
increased levels of GRP78 in HeLa cells leads to appreciable
increases of ER Ca2+ storage capacity [29].
The  role  of  GRP78  in  normal  and  diseased  outﬂow
pathways that induces the elevation of intraocular pressure has
not  been  demonstrated.  We  previously  demonstrated  that
Pro370Leu  mutant  myocilin  attenuated  the  induction  of
GRP78 and the phosphorylation of eIF2α [30]. Speciﬁcally,
HTM cells expressing Pro370Leu mutant myocilin showed a
selective decrease in GRP78 mRNA compared to wild-type
myocilin at the same age. This correlation suggested that
insufﬁcient GRP78 levels may contribute to TM cell death.
So, we hypothesize that the increasing levels of GRP78
may  be  beneﬁcial  in  preventing  POAG  associated  with
myocilin misfolding. However, the overexpression of GRP78
has not yet been studied in TM cells from POAG patients
(GTM) and non-diseased individuals (NTM). In this study, we
focus on investigating the expression of GRP78 in normal and
diseased HTM cells and on studing the relationship between
GRP78 and MYOC, which is the common mutant protein in
POAG.
METHODS
Patient information - clinical findings in primary open angle
glaucoma: Prior to the surgery, clinical data for each patient
were collected, including age, gender, use of prostaglandin
analogs, number of argon laser trabeculoplasties and other
ocular surgical interventions, type and duration of glaucoma,
IOP, and visual acuity. Glaucoma diagnoses were based on
careful  clinical  eye  examination,  including  slit  lamp
examinations,  optical  coherence  tomography,  gonioscopy,
fundus  photography  and  visual  field  examinations.  All
patients underwent slit lamp examination again the day before
surgery. All IOPs in the POAG group exceeded 20 mmHg at
the time of surgery. Visual acuity varied from 0.3 to 1.0.
Tissue procurement and cell culture: Normal human eyes
were obtained from the Zhongshan Ophthalmic Center Eye
Bank in Guangzhou, China. The procurement of tissue was
approved by the IRB Committee at the Sun Yat-sen University
in Guangzhou, China. Normal TM cells were derived from
eight human donor eyes, without any known ocular diseases,
for corneal transplantation, less than 24 h after death. The ages
of  the  donors  ranged  from  20  to  60  years.  After  written
informed consent, TM specimens from eight POAG patients
(15  to  60  years  old)  were  obtained  by  standard  surgical
trabeculectomy for therapeutic purposes, less than 1 h after
surgery. In brief, the human TM cells were carefully dissected
from the anterior segments and the whole corneal layer of the
human  donor  eyes.  The  explants  were  placed  in  24-well
culture plates (Corning Costar, Cambridge, MA) containing
Dulbecco’s Modified Eagle Medium (DMEM) which was
supplemented  with  15%  fetal  bovine  serum,  2  mM  L-
glutamine, penicillin (100 U/ml), and streptomycin (100 µg/
ml). Cells from the TM migrated from the explants within
approximately seven days and formed a confluent monolayer
in two to five days. Second- or third-passage cells were used
for all the experiments described here.
Tunicamycin (Tm) and staurosporine (STS) treatment: Stock
solutions of 1 μM Tm (an inducer of ER stress) and 0.1 μM
STS  (a  well  characterized  inducer  of  apoptosis)  were
dissolved in dimethyl sulfoxide (DMSO) and stored at 4 °C.
The NTM and GTM cells were treated with Tm and STS, as
mentioned below. All TM cells were divided into a control
and treatment groups. Treatment groups were grown in media
containing 1μM Tm or 0.1μ mol/L STS for six and 24h to
examine GRP78 expression, the others were grown in normal
media and received equivalent volumes of DMSO as a control.
Morphological  changes  in  the  primary  cultures  were
examined using light microscopy.
Cell viability: A Cell Titer 96® AQueous One Solution cell
proliferation  assay  (Promega,  Madison,  WI)  was  used  to
evaluate cell viability [18]. The NTM and GTM cells were
seeded in 96-well plates with an initial density of 5×103 cells
per  well  and  were  incubated  for  24  h  (reaching  80%
confluence) before the copolymers were added. Then, serum-
supplied DMEM was replaced with 200 µl of serum and
antibiotic-free DMEM that contained various concentrations
(0,  1,  3,  10,  30,  and  100  uM)  of  Tm.  After  six  or  24  h
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and antibiotic-free DMEM that contained 20 μl of Cell Titer
96® AQueous One Solution Reagent (MTS). Finally, after 4
h of additional incubation, a micro-plate reader (Bio-Rad Lab
Inc., Hercules, CA) measured the absorbance of each well at
570  nm.  Cell  viability  was  calculated  according  to  the
following equation:
Cell viability (%)=(OD570 [sample]/OD570 [control) × 100;
where OD570 (sample) represents the average absorbance of
cells treated with media that contain different concentrations
of  cationic  polymer  complexes,  and  OD570  (control)
represents the average absorbance of cells treated only with
an equal volume of serum-free DMEM.
Confocal  laser  scanning  microscopy:  Cells  seeded  on
polylysine (10 μg/ml)-coated glass chamber slides at a density
of 2,000 cells/chamber were washed, fixed in ice-cold 4%
paraformaldehyde for 15 min, and permeabilized in 100 mM
phosphate  buffer  containing  0.2%  TritonX-100  (Sigma-
Aldrich,  St.  Louis,  MO)  for  4  min.  The  cells  were  then
incubated  with  5%  bovine  serum  albumin  (BSA),
immunolabeled  with  anti-GRP78  (1:500;  Santa  Cruz
Biotechnology, Inc., Santa Cruz, CA) and anti-MYOC (1:500;
Santa Cruz Biotechnology, Inc.) at room temperature for 1 h.
Normal goat IgG was used instead of anti-GRP78 in some
experiments to serve as a negative control. After incubation
with  the  primary  antibody,  the  cells  were  washed  and
incubated for 1h with Cy3-anti-GRP78 (1:500; Santa Cruz
Biotechnology,  Inc.)  and  FITC-anti-MYOC  (1:500;  Santa
Cruz Biotechnology, Inc.) for 1 h. After additional washes,
the cells were mounted using fluorescence mounting medium
(Applygen Technologies, Inc., Beijing, China). The staining
pattern  was  visualized  using  a  Zeiss  100M  confocal
microscope (Carl Zeiss Jena GmbH, Jena, Germany).
Real-time reverse transcription polymerase chain reaction:
To examine GRP78 mRNA expression, NTM and GTM cells
were seeded in 6-well plates at a density of 1.4×105 cells per
well. After the cells were incubated for 24h, they were treated
in media without fetal bovine serum (FBS; HyClone, Logan,
UT) to achieve synchronization. They were then exposed to
1 µM Tm or 0.1µM STS in 10% FBS DF12 for six and 24 h.
Total RNA was extracted using an RNeasy Micro Kit (Qiagen
Inc., Valencia, CA) according to the manufacturer’s protocol.
The total RNA was divided into microtubes, and frozen to −80
oС.  The  yield  and  purity  of  RNA  were  determined
spectrophotometrically  at  260  nm,  and  the  cDNA  was
prepared using the ReverAidTM First Stand cDNA Synthesis
Kit  (Fermentas  Inc.,  Hanover,  MD).  A  real-time  reverse
transcription polymerase chain reaction (RT–PCR) procedure
was conducted according to the manufacturer’s protocol for
the SYBR® Premix Ex TaqTM Kit (Takara Biotechnology,
Otsu, Shiga, Japan). Reaction participants were assembled in
a 96-well optical reaction plate (Applied Biosystems, Foster
City, CA), where each well contained SYBR® Premix Ex
Taq™ (2×), 200 nM of forward primer, 200nM of reverse
primer, ROX Reference Dye (50×), and cDNA solution, with
a total volume of 20 μl. For GRP78, the forward primer was
5′-GAC ATC AAG TTC TTG CCG TT-3′, and the reverse
primer was 5′-CTC ATA ACA TTT AGG CCA GC-3′. The
mRNA level of glyceraldehydes-3-phosphate dehydrogenase
(GAPDH) was also measured in each sample as an internal
control. The forward primer was 5′-GAG TCA ACG GAT
TTG GTC GT-3′, and the reverse primer was 5′-CAT GGG
TGG AAT CAT ATT GGA-3′. Reactions were performed
under the following conditions: 10 min at 95 °C for the initial
denaturation, 40 cycles of amplification (5 s at 95 °C), and
annealing  for  31  s  at  60  °C,  using  the  ABI  Prism  7000
Sequence  Detection  System  (Applied  Biosystems).  The
threshold cycle (Ct) values were determined by ABI Prism
7000  Software  (Applied  Biosystems)  and  normalized  by
subtracting  the  Ct  GAPDH  values.  All  experiments  were
performed in triplicate, and the relative amount of mRNA of
each  sample  was  calculated  using  the  2-ΔCt  method  in
individual experiments [19].
Western  blot  analysis:  After  treatment,  HTM  cells  were
treated with cold phosphate buffered saline (PBS, pH7.4) and
lysed  in  100  µl  of  protein  extraction  reagent  (Pierce,
Rockford, IL). After boiling for 5 min, the cell lysates were
centrifuged at 4 °C for 15 min and the supernatants were
collected and stored at −80 °C. Each sample (20 µg) was
loaded  onto  10%  SDS-polyacrylamide  gels  and
electrophoresed at 100 V for 1 h. The resolved proteins were
transferred electrically to polyvinylidene difluoride (PVDF)
membranes (Invitrogen, Carlsbad, CA) and incubated with
0.5%  skim  milk  in  tris-buffered  saline  containing  0.05%
Tween-20 (TPBS) for 1.5 h. The membrane was probed with
goat polyclonal GRP78 antibody (1:1,000 final dilution; Santa
Cruz Biotechnology, Inc.) and developed with Phototope-
HRP  rabbit  anti-goat  polyclonal  antibody  (1:1,000  final
dilution; Santa Cruz Biotechnology, Inc.). Blotting signals
were  detected  by  chemiluminescence  reagents  using
SuperECL Plus (Applygen Technologies, Inc.) following the
manufacturer’s instructions. The amount of β-actin protein in
each sample was also measured as an internal control.
Statistical analysis: GraphPad Prizm 5 software (GraphPad
Software Inc., San Diego, CA) and SPSS version 13.0 for
windows (SPSS Science Inc., Chicago,IL) statistical software
packages were used. The relative amount of mRNA in each
sample was compared with untreated NTM and calculated
using  the  2-ΔCt  method  in  individual  experiments.  After
quantification of western blot data, the mean±SD are shown.
T-test analysis was used for data obtained from NTM and
GTM  cells.  A  one-way  ANOVA  test  was  performed  for
comparisons  among  multiple  groups,  and  statistical
significance was set at p<0.05. All assays were performed
using at least three separate experiments in triplicate, and data
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cells (controls).
RESULTS
Morphology changes in HTM cells treated with Tm and STS:
Apoptosis was induced in TM cells using Tm (1 uM) or STS
(0.1 uM), and morphological changes were assessed using
light microscopy. The NTM and GTM cells were cultured and
characterized as previously described [22,23]. As shown in
Figure 1, GTM cells appeared to be larger and more irregular
in shape compared to NTM cells. After being incubated with
Tm (1 μM) or STS (0.1 μM) for 24 h and using phase-contrast
light microscope, it was found that the cells in the treatment
groups shrunk compared to those in the control group (Figure
1), especially in the STS-treated group. At the same time, the
density of NTM and GTM cells was decreased after being
treated with the drugs.
Detecting cytotoxicity of Tm and STS: A tetrazolium-based
viability assay, based on the bioreduction of the MTS reagent
into  formazan  by  living  cells,  was  used  to  study  the
cytotoxicity of Tm and STS. The TM cells exhibited cell
viability of more than 80% at concentrations of 1 uM, and the
Figure 1. Morphology of TM cells before and after Tm or STS
treatment. NTM and GTM cells were obtained and cultured using
identical culture protocols. GTM cells were slightly larger compared
to NTM cells. The morphology of the cells became thin and slender
after treatment with 1 μM Tm or 0.1 μM STS for 24 h as compared
to untreated controls, especially in the STS-treated group. Gross
morphological  alterations  (cell  shrinkage,  low  density)  were
apparent at 24 h after STS treatment. Scale bar=30 μm.
number of viable cells was significantly higher than those
treated with STS at concentrations of 0.1 μg/ml and above
(Figure 2).
Attenuated GRP78 expression in GTM compared to NTM
cells: A real-time PCR assay revealed that GRP78 mRNA in
GTM  cells  exhibited  a  significant  decrease  (65.97±3.8%,
mean±SD, n=3, p<0.05) compared to NTM cells (Table 1,
Figure  3).  The  relative  expression  developed  into
66.89±1.7%, 66.54±1.9% when cells were treated with Tm for
six or 24 h (Table 1, Figure 3A) and 79.10±1.6%, 52.10±3.1%
with STS for six or 24 h (Table 1, Figure 3B). Based on
western blot analysis, the expression of GRP78 protein was
attenuated (80.49±4.2%, mean±SD, n=3, p<0.05) compared
with NTM cells (Table 2, Figure 4). The relative expression
became 72.78±2.1%, 71.54±2.2% when cells were treated
with Tm (Table 2, Figure 4B) and 38.96±3.2%, 44.89±2.4%
when cells were treated with STS (Table 2, Figure 4C) for six
h  and  24  h,  respectively.  β-actin  was  used  as  an  internal
loading control.
Tm  upregulated  GRP78  expression  in  a  time-dependent
manner, while STS decreased GRP78 protein expression in
GTM cells: The upregulation of GRP78 expression in human
TM cells was obvious when the cells were treated with Tm
(Figure 3A, Figure 4A,B). Induction of GRP78 was evident
after 6 h of treatment and continued to increase. Maximal
Figure 2. Determination of dynamic alteration of cell proliferation in
activated HTM cells after exposure to Tm or STS by MTS assay.
Data were presented as the percentage of viable cells compared with
untreated (control) cells (mean±SD, n=6).
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1125induction of GRP78 in TM cells was about 2.6 fold at 24 h
after treatments with Tm (Table 3 and Table 4, p<0.05). There
was a significant difference between six h and 24 h of Tm
treatment (p<0.05). After exposure to Tm and following ER
stress, increased GRP78 protein levels were detected in all
cells. However, a lower fold change of the protein (2.367
versus 2.581 for 24 h exposure) was found in GTM cells
compared to NTM cells (p<0.05). Staurosporine is an inducer
of apoptosis. After being treated with STS, the expression of
GRP78 protein decreased (Table 4, Figure 4) in GTM cells
Figure 3. Both NTM and GTM cells were treated as indicated, and
normalized GRP78 mRNA levels were measured using real time
PCR  and  were  shown  relative  to  levels  in  untreated  cells.  All
experiments were performed in triplicate, and the relative amount of
mRNA in each sample was calculated using the 2-ΔCt method in
individual experiments. Values represent the means±SDs, ANOVA
test, the double asterisk indicates a p<0.05; Student’s t-test, and the
asterisk indicates a p<0.05.
compared to NTM cells (p<0.05). No significant difference
was detected between six h and 24 h of treatment.
Colocalization  of  GRP78  and  myocilin  in  TM  cells:  The
expression of GRP78 was detected in both NTM and GTM
cells  (Figure  5).  Immunostaining  of  GRP78  and  confocal
microscopy demonstrated granular and diffused distribution
Figure 4. Normalized GRP78 protein levels were measured in cells
(treated with Tm or STS) using western blot analysis and were shown
relative to levels in no treatment cells. Meanwhile, the expression
peak of GRP78 protein appeared at 24 h after treatment with Tm.
After exposure to Tm and following ER stress, increased GRP78
protein levels were detected in all cells, however, a lower fold change
of the protein (2.564 versus 2.710 for 24 h exposure) was found in
GTM cells compared to NTM cells (p<0.05). Error bars represent
SDs from three individual experiments, ANOVA test, the double
asterisk indicates a p<0.05; Student’s t-test, and the asterisk indicates
a p<0.05.
TABLE 1. RELATIVE EXPRESSION OF GRP78 MRNA.
  Treatment
Group Control Tm, 1 μM, 6 h Tm, 1 μM, 24 h STS, 0.1 μM, 6 h STS, 0.1 μM, 24 h
NTM (mean±SD) n=3 1.000±0.000 2.138±0.032 2.604±0.062 1.369±0.038 1.119±0.061
GTM (mean±SD) n=3 0.660±0.038 1.430±0.037 1.732±0.049 1.083±0.022 0.583±0.035
GTM/NTM 65.97±3.8%* 66.89±1.7%* 66.54±1.9%* 79.10±1.6%* 52.10±3.1%*
The asterisk indicates a p<0.05.
TABLE 2. RELATIVE EXPRESSION OF GRP78 PROTEIN.
 
Treatment
Group Control Tm, 1 uM, 6 h Tm, 1 uM, 24 h STS, 0.1 uM, 6 h STS, 0.1 uM, 24 h
NTM (mean±SD) n=3 1.000±0.033 1.495±0.018 2.664±0.074 1.042±0.038 0.793±0.023
GTM (mean±SD) n=3 0.805±0.042 1.088±0.031 1.906±0.058 0.406±0.033 0.356±0.019
GTM/NTM 80.49±4.2%* 72.78±2.1%* 71.54±2.2%* 38.96±3.2%* 44.89±2.4%*
The asterisk indicates a p<0.05.
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1126throughout the cytoplasm in NTM cells. The GRP 78 and
myocilin were partly overlapped in the NTM cells, while the
overlap range turned into total cytoplasm in GTM and treated
NTM cells. Perinuclear aggregation of GRP78 expression was
observed  in  GTM  cells  (control,  Tm-treated  group)  and
treated NTM cells (white arrow).
DISCUSSION
A decreased number of TM cells was reported as a clinical
feature in patients with POAG. Apoptosis has been suggested
as being one of the mechanisms by which TM cells die in
glaucoma [9,31,32]. The direct molecular mechanism on how
TM cell death would lead to an increase in aqueous outﬂow
resistance is unclear, but it is more than likely that a severe
impairment  of  TM  homeostasis  caused  by  TM  cell  death
should critically impair the main function of the TM. The
78 kDa glucose-regulated protein is involved in polypeptide
translocation across the ER membrane and also acts as an
apoptotic regulator by protecting the host cell against ER
stress-induced cell death. However, the mechanism by which
GRP78 exerts its cytoprotective effect is still undetermined.
Here, we provide evidence that GRP78 expression is down-
TABLE 3. RELATIVE GRP78 MRNA EXPRESSION OF CONTROL.
 
Treatment
Group Tm, 1uM, 6h Tm, 1uM, 24h STS, 0.1uM, 6h STS, 0.1uM, 24h
NTM 2.138±0.032 2.604±0.062 1.369±0.038 1.119±0.061
GTM 2.16±0.056 2.624±0.074 1.636±0.032 0.881±0.053
GTM/NTM 1.010±0.056 1.008±0.026 1.195±0.018 0.787±0.053*
The asterisk indicates a p<0.05.
TABLE 4. RELATIVE GRP78 PROTEIN EXPRESSION OF CONTROL.
 
Treatment
Group Tm, 1 uM, 6 h Tm, 1 uM, 24 h STS, 0.1 uM, 6 h STS, 0.1 uM, 24 h
NTM 1.587±0.023 2.710±0.021 1.026±0.064 0.821±0.012
GTM 1.562±0.044 2.564±0.035 0.456±0.009 0.444±0.003
GTM/NTM 0.984±0.024 0.946±0.051* 0.444±0.015* 0.549±0.032*
The asterisk indicates a p<0.05.
Figure 5. GRP78 and myocilin (MYOC) were expressed in both NTM and GTM cells, and exhibited a diffused distribution throughout the
cytoplasm in NTM cells. The expression pattern of GRP78 and MYOC was most overlapping in GTM and treated NTM cells. Perinuclear
aggregation of GRP78 expression was observed in GTM and treated NTM cells (white arrow). The Tm slightly upregulated GRP78 expression
and STS down-regulated it, while the expression of MYOC did not show much difference. Scale bar=10 μm.
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1127regulated in GTM cells compared to NTM cells, that GRP78
can exist as an ER transmembrane protein, and that it can co-
localize  with  myocilin.  This  was  confirmed  using
fluorescence microscopy.
Studies in cultured HTM cells have suggested that the
UPR in response to aggregation of MYOC would represent
one disease mechanism in the pathogenesis of intraocular
pressure  and  glaucoma  [16,17].  Oxidative  stress,  glyco-
starvation,  calcium  homeostasis,  and  misfolded  protein
accumulation can all lead to ER stress and activation of UPR
[15]. UPR elicits paradoxical outputs, inducing cytoprotective
functions that re-establish homeostasis and cell destroying
functions  that  promote  apoptosis.  When  these  adaptive
responses are not sufficient to relieve ER stress, apoptosis is
induced  [33].  Cytoprotective  outputs  will  outweigh  pro-
apoptotic factors at this point, which would be helped by the
relatively longer mRNA and protein half-lives of factors such
as GRP78 [34]. Due to the anti-apoptotic property of GRP78,
its induction has been reported as a pro-survival factor for cells
undergoing ER stress [26,35].
Overexpression of GRP78 is more necessary needed in
cells undergoing physiologic or pathological stress. Previous
studies  demonstrated  that  stress  may  cause  expression  of
GRP78, and that the increase appears to be important for the
survival of cancer cells [36-38].The mechanism by which
GRP78 overexpression contributes to cancer proliferation is
linked to its ability to inactivate pro-apoptotic pathways and
activate pro-survival pathways for cancer cells [35]. Reddy et
al.  [39]  provided  evidence  that  specific  GRP78
overexpression is sufficient to confer drug resistance in at least
two cell types, and that the protective effect of GRP78 is
dependent on a functional ATP-binding domain. Our results
show that ER stress chaperone GRP78 presents a low level of
both mRNA and protein in GTM cells compared with NTM
cells. This down-regulation of the ER stress response might
disrupt  the  protective  mechanism,  thus  increasing  the
vulnerability  of  GTM  cells  to  ER  stress.  This  correlation
suggests that insufﬁcient GRP78 levels contribute to the loss
of the cytoprotective function, leading to the death of TM
cells.
Low expression of GRP78 alters the susceptibility of TM
cells  to  damage  stimulus.  Two  signaling  pathways  are
proposed to induce expression of GRP78: one responsive to
the disturbance of intracellular calcium homeostasis, the other
to the inhibition of protein glycosylation [38]. GRP78 are
Ca2+-binding proteins in the ER, the intracellular Ca2+ levels
have been implicated as potent regulators in the expression of
the  GRP78.  Moreover,  GRP78  is  also  shown  to  prevent
apoptosis that arises from disturbance of intracellular Ca2+,
suggesting a critical role of GRP78 in regulating cellular Ca2+
homeostasis [40]. He et al. [41] found that POAG patients’
TM cells have a lower ATP level and ΔΨm compared to non-
diseased TM cells. The possible mechanism for attenuated
GRP78 expression is that it lowers the ER calcium level by
releasing calcium stores, which affects protein secretion and
causes accumulation of protein in the ER [42,43].
It has been found that GRP78 is located in the cytoplasm
and associated with caspase-7 [39]. In cooperation with other
chaperones,  Hsp70  stabilizes  pre-existing  proteins  against
aggregation  and  mediates  the  folding  of  newly  translated
polypeptides in the cytosol and within organelles. There is
also ample evidence that myocilin is a secreted protein; an
additional or exclusive intracellular function that has been
investigated by various authors [44-46]. In our study, GRP78
expression displayed a diffused distribution throughout the
cytoplasm. The overlap of GRP78 staining with the myocilin
apparatus also indicates its association with secretory vesicles.
Such interference would vary in type and extent according to
the  type  of  mutation  present,  but  even  a  relatively  slight
interference  in  endocytoplasmic  reticulum  function  would
likely decrease cell viability.
Interestingly,  O’Brien’s  [47]  original  observation  that
myocilin is localized to the golgi in human Schlemm’s canal
endothelial cells might also be related to our ﬁndings. What
does localization of the GRP78 protein to myocilin mean? The
endocytoplasmic  reticulum  is  the  site  within  where
glycosylation of proteins occurs, consistent with evidence that
myocilin is glycosylated before it is secreted. The mutant
MYOC  protein  induces  ER  stress  and  the  resultant  UPR
induces apoptosis in TM cells, which then leads to increased
resistance  to  aqueous  humor  outflow,  elevated  IOP,  and,
ultimately, glaucoma [48].
A  growing  body  of  evidence  suggests  that  ER  stress
causes a buildup of unfolded proteins within the ER, where
molecular chaperones (typically GRP78 and PDIs) greatly
increased, while the synthesis of new proteins is inhibited
[49,50]. Current studies highlight the importance of GRP78
as  an  anti-apoptotic  protein  and  shed  new  light  on  the
mechanisms underlying the relationship between ER stress
[51,52], UPR, and programmed cell death. The results could
have  broad  implications  for  our  understanding  of  the
mechanism by which cells couple ER stress to the cell death
program and the mechanism by which the associated decision
between  apoptosis  inhibition  and  activation  is  controlled.
Additionally, the results of the present study demonstrate that
the induced GRP78 localizes to mitochondria in response to
ER stress [53]. Such a mechanism could be a factor in the best-
documented evidence of the cellular pathology of the outﬂow
pathway and the loss of TM cells in patients with POAG
[30]. The correlation between the intracellular myocilin of
GRP78 and its possible associations with other proteins has
yet to be investigated.
In summary, we found that GRP78 was down-regulated
in GTM cells compared to NTM cells, even when treated with
an ER stress inducer. Myocilin protein was partly colocalized
with  GRP78  in  TM  cells.  Nevertheless,  the  possible
Molecular Vision 2010; 16:1122-1131 <http://www.molvis.org/molvis/v16/a124> © 2010 Molecular Vision
1128mechanism  and  biologic  function  of  GRP78  in  cellular
protection warrants further study, the results of which may
confirm  the  idea  that  such  correlation  may  occur  due  to
GRP78  inactivation,  thus  helping  to  specify  the  diverse
functions of GRP78 in response to ER stress.
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